Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/7/26 19:56 | 10/5/26 | BLLN | Health | Health | Medical Laboratories | Ten Bosch John Roderick | CA | O | SVP of L | 7 | S | -1,564 | 110.37 | 0 | -14 | 29 | D | |||||||||||||||
10/7/26 19:56 | 10/5/26 | BLLN | Health | Health | Medical Laboratories | Tsao David | CA | DO | CTO | 6 | S.d | -8,981 | 107.78 | 0 | -83 | 1 | D | |||||||||||||||
9/30/26 20:33 | 9/28/26 | BLLN | Health | Health | Medical Laboratories | Atay Oguzhan | CA | DO | CB,CEO | 4 | S.d | -12,857 | 126.21 | 0 | -102 | 163 | M | |||||||||||||||
9/21/26 19:00 | 9/17/26 | BLLN | Health | Health | Medical Laboratories | Lynch Thomas P. | CA | O | See Rema | 1 | S.d | -3,874 | 110.33 | 0 | -35 | 1 | D | |||||||||||||||
8/4/26 16:32 | 7/31/26 | BLLN | Health | Health | Medical Laboratories | Sakakibara Shan Riku | CA | O | Chief Pr | 1 | S | -561 | 140.21 | 0 | -4 | 200 | D | |||||||||||||||
7/20/26 19:38 | 7/16/26 | BLLN | Health | Health | Medical Laboratories | Johnson Nancy Joann | CA | O | See Rema | 1 | S | -1,822 | 128.29 | 0 | -14 | 7 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |